Ocean Biomedical Receives Notice From Nasdaq That It Is Not In Compliance With Listing Rule
Ocean Biomedical Receives Notice From Nasdaq That It Is Not In Compliance With Listing Rule
Ocean Biomedical收到納斯達克的通知，稱其不符合上市規則
As previously reported in its SEC filings, Ocean Biomedical is delayed in filing the Form 10-Q as a result of previously disclosed developments with respect to filing of its 10-K for the year ended December 31, 2023.
正如先前在美國證券交易委員會文件中所報道的那樣，Ocean Biomedical延遲提交10-Q表格，原因是此前披露了截至2023年12月31日止年度的10-K申報進展情況。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。